missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Cytokeratin 18 Recombinant Protein
Description
This product contains purified recombinant human Cytokeratin-18 protein with an N-terminal hexahistidine tag. This product may be used as a positive control in many immunological assays.
Cytokeratin 18 (Keratin 18, KRT18, type I cytoskeletal 18) belongs to the type A (acidic) subfamily of low molecular weight keratins, exists in combination with cytokeratin 8. Tissues from gastrointestinal tract, respiratory tract and urogenital tract, as well as endocrine and exocrine tissues and mesothelial cells are positive for cytokeratin 18. Further, cytokeratin 18 is found primarily in non-squamous epithelia and is present in a majority of adenocarcinomas and ductal carcinomas, but not in squamous cell carcinomas. Hepatocellular carcinomas express only cytokeratins 8 and 18. Mutations in the cytokeratin 18 gene have been linked to cryptogenic cirrhosis. Two transcript variants encoding the same protein have been found for the cytokeratin 18 gene. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays.
Specifications
Specifications
| Accession Number | P05783 |
| Concentration | 0.8 mg/mL |
| For Use With (Application) | Control, Western Blot |
| Formulation | tris HCl with 50% glycerol, 5 mM EDTA and no preservative; pH 8 |
| Gene ID (Entrez) | 3875 |
| Name | Human Cytokeratin 18 |
| pH Range | 8.0 |
| Quantity | 10 μg |
| Source | E. coli |
| Immunogen | N/A |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?